NFKB1 and cancer: Based on the pioneering study showing that GSK- 3β is required for NF-κB activation in mouse embryonic hepatocyte survival [34], previous studies focused on the role of GSK-3β in regulating NF-κB activity in cancer cells [25, 35, 36].